In a 26-year-old male presenting to the emergency department with acute mental status change, mutism, waxy flexibility and other catatonic features, which medication should be administered emergently?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intravenous Lorazepam is the Indicated Treatment

For this 26-year-old male with acute catatonia presenting with mutism, staring, and waxy rigidity, intravenous lorazepam (Ativan) should be administered immediately in the emergency department. This is the first-line treatment for catatonia with the strongest evidence base and fastest response rate 1, 2, 3.

Why Lorazepam is the Correct Choice

Benzodiazepines, specifically lorazepam, are the cornerstone of acute catatonia treatment with response rates of 85-100% when administered promptly 3, 4, 5. In a study of 14 patients with catatonic schizophrenia, lorazepam achieved an 85.7% response rate within 2 hours, with 100% total response when combined with diazepam if needed 3. The 2023 British Association for Psychopharmacology guidelines explicitly recommend lorazepam as first-line treatment 2.

Dosing approach:

  • Start with 1-2 mg IV lorazepam immediately
  • May repeat every 30-60 minutes as needed
  • Can escalate to very high doses (up to 8-12 mg/day or more) if initial doses fail 2
  • Monitor for response within 2 hours

Why the Other Options are Wrong

Intramuscular haloperidol lactate is contraindicated - This is the most dangerous option. Antipsychotics, particularly first-generation agents like haloperidol, can precipitate or worsen catatonia and may trigger neuroleptic malignant syndrome, a potentially fatal complication 1, 2. The guidelines explicitly caution against antipsychotics in undiagnosed catatonia 6.

Intravenous diphenhydramine has no role - This anticholinergic agent is used to treat extrapyramidal side effects from antipsychotics, not catatonia itself. It would not address the underlying syndrome and could potentially worsen confusion 6.

Intramuscular glucagon is irrelevant - Glucagon treats hypoglycemia, which has already been excluded by normal labs in this patient. This option is a distractor.

Critical Clinical Pitfalls

The most dangerous error would be administering haloperidol, mistaking catatonia for simple agitation or psychosis. Key distinguishing features of catatonia that should trigger benzodiazepine treatment include:

  • Waxy flexibility (maintaining imposed postures) - pathognomonic for catatonia
  • Mutism with preserved consciousness
  • Staring without interaction despite being awake
  • Absence of agitation - this patient is quiet and cooperative

This presentation requires at least 3 motor signs from decreased, increased, or abnormal psychomotor activity categories to diagnose catatonia 7, 8. This patient clearly meets criteria with mutism (decreased), waxy rigidity (abnormal), and staring (decreased).

What Happens Next

After lorazepam administration:

  • Expect response within 10-30 minutes IV (peak effect at 15-20 minutes) 9
  • If no response to initial 2 mg, give additional 1-2 mg doses
  • If benzodiazepines fail after adequate dosing, electroconvulsive therapy (ECT) becomes the definitive treatment 2, 4, 5
  • Continue investigating underlying causes (though toxicology and basic workup are negative here)

The normal vital signs, negative toxicology, and absence of medical red flags make this a straightforward case for immediate benzodiazepine challenge. The dramatic and rapid response to lorazepam is both diagnostic and therapeutic for catatonia 3, 4.

References

Research

Catatonia.

Nature reviews. Disease primers, 2024

Research

The diagnosis and treatment of catatonia.

Clinical medicine (London, England), 2023

Research

Clinical manifestations, diagnosis, and empirical treatments for catatonia.

Psychiatry (Edgmont (Pa. : Township)), 2007

Research

Catatonia: a review.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2008

Research

Catatonia in ICD-11.

BMC psychiatry, 2025

Research

Catatonia: American Psychiatric Association Resource Document.

Journal of the Academy of Consultation-Liaison Psychiatry, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.